BioSpace News Archive

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the third quarter ended September 30, 2021 and provided corporate updates.

Caraway Therapeutics announced that the Company is scheduled to participate at two upcoming investor conferences.

Precision BioSciences, Inc. today announced financial results for the third quarter ended September 30, 2021 and provided a business update.

Arbutus Biopharma Corporation today announced that the Company will participate in a virtual fireside chat at the Jefferies London Healthcare Conference.

Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version of its next-generation Microlyte® Matrix wound dressing that can kill bacteria hidden in biofilms.

Kaleido Biosciences, Inc. today announced the appointment of Alison Long, M.B.B.Ch., Ph.D., to its leadership team as Chief Medical Officer, effective December 15, 2021.

Monte Rosa Therapeutics, Inc. today reported business highlights and financial results for the third quarter, ended Sept. 30, 2021.

Decibel Therapeutics today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

According to the report, the global intravascular ultrasound devices market was valued at US$ 600 Mn in 2020.

Transparency Market Research has published a new report titled ‘Healthcare Information Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global health care information systems market was valued at US$ 227,021.4 Mn in 2017 and is projected to expand at a CAGR of 9.6% from 2018 to 2026.